Since the initial report of coronavirus disease (COVID-19) from the City of Wuhan, China in December 2019, there have been multiple cases globally. Reported here are 11 cases of COVID-19 at this hospital; all of the patients in question presented with relative bradycardia. The severity of the disease was classified into four grades. Of the patients studied, 3 with mild COVID-19 and 3 with moderate COVID-19 improved spontaneously. Lopinavir/ritonavir was administered to 3 patients with severe COVID-19 and 2 with critical COVID-19. Both patients with critical COVID-19 required mechanical ventilation and extracorporeal membrane oxygenation. Both patients with critical COVID-19 had a higher fever that persisted for longer than patients with milder COVID-19. The respiratory status of patients with critical COVID-19 worsened rapidly 7 days after the onset of symptoms. Relative bradycardia may be useful in distinguishing between COVID-19 and bacterial community-acquired pneumonia. In patients who have had a fever for > 7 days, the condition might worsen suddenly.
これもNCGMからです
COVID-19患者は比較的徐脈を呈し、発熱が7日続く場合に急激な悪化を起こしやすい
COVID-19 can suddenly become severe: a case series from Tokyo, Japan
https://t.co/GLSKwKGs0Z
https://t.co/qG1xkijSC1 https://t.co/rh9oWrypo2
COVID-19 can suddenly become severe
https://t.co/NCTtgcSARC
COVID-19の11例すべて相対的徐脈。軽度COVID-19は3例、中等度のCOVID- 19は3例が自然に改善。重症COVID-19患者3例と重篤COVID-19患者2例にロピナビル/リトナビルを投与。重篤COVID-19患者は2例とも機械換気と体外膜酸素療法を必要とした